Article
Hyperactivity of Human DNase I Variants
1 May 1998
Abstract excerpt
Human DNase I, an enzyme used to treat cystic fibrosis patients, has been engineered to more effectively degrade double-stranded DNA to lower molecular weight forms by introducing positively charged amino acids at positions that can interact favorably with the proximal negatively charged phosphate groups of the DNA. A series of combination mutants having from one to six additional basic residues compared with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
